Aspen Pharmacare has signed a deal with Indian firm Laurus for the supply of active pharmaceutical ingredients (APIs) which are used for making HIV/Aids drugs.

The deal with Laurus, which is one of the world’s largest API suppliers, will give the South African government access to competitively priced APIs, according to Aspen senior executive Stavros Nicolaou...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now